XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash Flows From Operating Activities:    
Net income/(loss) $ 23,213 $ 72,784
Adjustments to reconcile net income/(loss) to net cash provided by operating activities:    
Net (gain)/loss on residential whole loans 11,095 (129,174)
Impairment and other net (gain)/loss on securities and other portfolio investments, net 4,112 (2,932)
Net gain on real estate owned (735) (3,936)
Accretion of purchase discounts and amortization of purchase premiums on residential whole loans and securities (3,327) (4,507)
Provision/(reversal of provision) for credit losses on residential whole loans and other assets 649 (4)
Net (gain)/loss on derivatives used for risk management purposes (23,182) 42,879
Net (gain)/loss on securitized debt measured at fair value through earnings 20,169 48,846
Net margin received/(paid) for derivatives used for risk management purposes (5,112) (28,428)
Net other non-cash (gains)/losses included in net income 14,103 5,674
(Increase)/decrease in other assets 19,397 (20,010)
Increase/(decrease) in other liabilities (6,915) 11,471
Net cash provided by/(used in) operating activities 53,467 (7,337)
Cash Flows From Investing Activities:    
Purchases and origination of residential whole loans, loan related investments and capitalized advances (761,214) (459,012)
Proceeds from sales of residential whole loans 151,664 263,014
Principal payments on residential whole loans and loan related investments 402,354 321,626
Purchases of securities 0 (305,858)
Proceeds from sales of securities and other assets 0 0
Principal payments on securities 8,081 5,755
Proceeds from sales of real estate owned 24,217 33,968
Other investing activities 83,496 (6,926)
Net cash provided by/(used in) investing activities (91,402) (147,433)
Cash Flows From Financing Activities:    
Principal payments on financing agreements with mark-to-market collateral provisions (290,021) (766,604)
Proceeds from borrowings under financing agreements with mark-to-market collateral provisions 438,616 640,498
Principal payments on other collateralized financing agreements (576,135) (415,443)
Proceeds from borrowings under other collateralized financing agreements 482,499 778,400
Payment made for other collateralized financing agreement related costs (1,340) (4,602)
Redemption of convertible senior notes (39,831) 0
Proceeds from issuance of senior notes 110,626 0
Proceeds from issuances of common stock, net of expenses (20) 17
Payments made for the repurchase of common stock (1,491) 0
Dividends paid on preferred stock (8,219) (8,219)
Dividends paid on common stock and dividend equivalents (35,789) (35,769)
Net cash provided by/(used in) financing activities 78,895 188,278
Net increase/(decrease) in cash, cash equivalents and restricted cash 40,960 33,508
Cash, cash equivalents and restricted cash at beginning of period 488,211 494,081
Cash, cash equivalents and restricted cash at end of period 529,171 527,589
Supplemental Disclosure of Cash Flow Information    
Cash paid for interest 122,746 87,057
Non-cash Investing and Financing Activities:    
Transfer from residential whole loans to real estate owned 19,342 20,925
Dividends and dividend equivalents declared and unpaid $ 36,015 $ 35,756